Shelton Capital Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-19,188
Closed -$3.53M 855
2021
Q2
$3.53M Hold
19,188
0.13% 169
2021
Q1
$2.93M Buy
19,188
+1,306
+7% +$200K 0.1% 190
2020
Q4
$2.79M Hold
17,882
0.13% 162
2020
Q3
$2.05M Hold
17,882
0.08% 254
2020
Q2
$2.01M Sell
17,882
-208
-1% -$23.3K 0.11% 175
2020
Q1
$1.62M Sell
18,090
-600
-3% -$53.9K 0.12% 158
2019
Q4
$2.02M Buy
18,690
+347
+2% +$37.5K 0.11% 166
2019
Q3
$1.8M Sell
18,343
-2,000
-10% -$196K 0.11% 171
2019
Q2
$2.67M Buy
20,343
+17,593
+640% +$2.3M 0.15% 129
2019
Q1
$20.3K Sell
2,750
-17,593
-86% -$130K 0.08% 230
2018
Q4
$1.98M Hold
20,343
0.13% 141
2018
Q3
$2.83M Hold
20,343
0.16% 120
2018
Q2
$2.53M Hold
20,343
0.16% 132
2018
Q1
$2.27M Buy
20,343
+2,356
+13% +$263K 0.15% 136
2017
Q4
$2.15M Hold
17,987
0.14% 141
2017
Q3
$2.52M Hold
17,987
0.17% 127
2017
Q2
$2.19M Buy
17,987
+1,202
+7% +$146K 0.15% 134
2017
Q1
$2.04M Buy
16,785
+1,475
+10% +$179K 0.14% 129
2016
Q4
$1.87M Hold
15,310
0.14% 147
2016
Q3
$1.88M Hold
15,310
0.16% 126
2016
Q2
$1.79M Sell
15,310
-162
-1% -$18.9K 0.16% 121
2016
Q1
$2.15M Buy
15,472
+1,064
+7% +$148K 0.2% 97
2015
Q4
$2.75M Buy
14,408
+683
+5% +$130K 0.27% 80
2015
Q3
$2.15M Buy
13,725
+2,246
+20% +$351K 0.24% 87
2015
Q2
$2.08M Buy
11,479
+417
+4% +$75.4K 0.21% 97
2015
Q1
$1.92M Buy
11,062
+1,872
+20% +$324K 0.21% 102
2014
Q4
$1.7M Buy
9,190
+1,508
+20% +$279K 0.2% 105
2014
Q3
$1.27M Buy
7,682
+1,133
+17% +$188K 0.17% 119
2014
Q2
$1.02M Buy
6,549
+440
+7% +$68.7K 0.14% 143
2014
Q1
$929K Buy
6,109
+517
+9% +$78.6K 0.14% 153
2013
Q4
$744K Buy
5,592
+726
+15% +$96.6K 0.11% 188
2013
Q3
$565K Buy
4,866
+156
+3% +$18.1K 0.09% 242
2013
Q2
$434K Buy
+4,710
New +$434K 0.08% 312